Top Markets
Coin of the day
BioSig Technologies, Inc. BioSig Technologies, Inc.

BioSig Technologies, Inc.

BSGM
株式のランク #10875
BioSig Technologies, Inc., along with its subsidiaries, operates as a medical... BioSig Technologies, Inc., along with its subsidiaries, operates as a medical technology enterprise. Its core innovation is the PURE EP (precise uninterrupted real-time evaluation of electrograms electrophysiology) system. This proprietary signal processing platform, merging specialized hardware and software, tackles well-known difficulties in electrophysiological signal acquisition, empowering electrophysiologists to instantaneously view and analyze vital cardiac signals. The system further enhances the collection of intracardiac signals and diagnostic data crucial for atrial fibrillation procedures. Moreover, it is specifically engineered to overcome persistent obstacles that traditionally slow down and complicate cardiac catheter ablation. BioSig also holds a research agreement with the University of Minnesota, targeting the development of new treatments for sympathetic nervous system disorders. Additionally, it has a strategic partnership with the Mayo Foundation for Medical Education and Research, focused on creating an advanced AI and machine learning software solution tailored for its PURE EP platforms. Established in 2009, BioSig Technologies, Inc. is headquartered in Westport, Connecticut.
株価
$5.52
最終同期: 2025-10-09
時価総額
$775.10M
変化(1日)
1.28%
変化(1年)
15.48%
US
取引 BioSig Technologies, Inc. (BSGM)

カテゴリー

BioSig Technologies, Inc.(BSGM)のP/E比率
August 2026 時点のP/E比率 TTM -4.96
BioSig Technologies, Inc. の最新の財務報告および株価によると、現在の P/E (TTM) は -4.96 です。2023 年末時点での P/E は -12.02 でした。
BioSig Technologies, Inc. の P/E 比率の履歴(2011 〜 2026)
各年末のP/E比率
P/E比率 変化
2026 (TTM) -4.96 -75.51%
2024 -20.25 68.43%
2023 -12.02 81.27%
2022 -6.63 -72.16%
2021 -23.83 14.23%
2020 -20.86 -42.24%
2019 -36.12 0.60%
2018 -35.90 23.88%
2017 -28.98 33.56%
2016 -21.70 12.40%
2015 -19.31 -39.46%
2014 -31.89 18.97%
2013 -26.81 -97.46%
2012 -1.06K -53.54%
2011 -2.27K 0.00%
類似企業や競合他社のP/E比率
企業 P/E比率 P/E比率の差
35.77 -821.37%
US
34.86 -802.97%
US
21.39 -531.27%
IE
20.90 -521.41%
US
- -
DE
P/E比率の読み方

株価収益率(P/E Ratio)は、企業の株価と1株あたり利益の関係を示します。
低いが正のP/Eは、現在の評価額に対して高い利益を上げている企業を示し、割安と見なされる可能性があります。高い負の(0に近い)P/Eは、損失が大きいことを示します。

P/Eが30を超えるか、負である企業は一般に「成長株」と見なされ、投資家は将来的な成長または黒字化を期待しています。

10未満の正のP/Eを持つ企業は一般に「割安株」と見なされ、既に収益性が高いが成長の余地は小さいと見なされます。